Roderick van den Bergh

1.4k total citations
26 papers, 494 citations indexed

About

Roderick van den Bergh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Roderick van den Bergh has authored 26 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Roderick van den Bergh's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (17 papers) and Global Cancer Incidence and Screening (5 papers). Roderick van den Bergh is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (17 papers) and Global Cancer Incidence and Screening (5 papers). Roderick van den Bergh collaborates with scholars based in Netherlands, Italy and Belgium. Roderick van den Bergh's co-authors include Giorgio Gandaglia, Derya Tilki, Massimo Valério, Piet Ost, Guillaume Ploussard, Igor Tsaur, Lionne D. F. Venderbos, Hendrik Borgmann, Alexander Kretschmer and Alberto Briganti and has published in prestigious journals such as The Journal of Urology, European Urology and Psychopharmacology.

In The Last Decade

Roderick van den Bergh

26 papers receiving 488 citations

Peers

Countries citing papers authored by Roderick van den Bergh

Since Specialization

Citations

This map shows the geographic impact of Roderick van den Bergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roderick van den Bergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roderick van den Bergh more than expected).

Fields of papers citing papers by Roderick van den Bergh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roderick van den Bergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roderick van den Bergh. The network helps show where Roderick van den Bergh may publish in the future.

Co-authorship network of co-authors of Roderick van den Bergh

This figure shows the co-authorship network connecting the top 25 collaborators of Roderick van den Bergh. A scholar is included among the top collaborators of Roderick van den Bergh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roderick van den Bergh. Roderick van den Bergh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enhancing Prostate Cancer Detection Accuracy in Magnetic Resonance Imaging–targeted Prostate Biopsy: Optimizing the Number of Cores Taken 2024 ·European Urology Open Science ·Fabio Zattoni, (unknown), Veeru Kasivisvanathan, Claudia Kesch, Giancarlo Marra, Alberto Martini, Ugo Giovanni Falagario, Timo Soeterik, Roderick van den Bergh, Paweł Rajwa, Giorgio Gandaglia	4
2	Health Policy for Prostate Cancer Early Detection in the European Union and the Impact of Opportunistic Screening: PRAISE-U Consortium 2024 ·Journal of Personalized Medicine ·Katharina Beyer, R. Leenen, Lionne D. F. Venderbos, Jozien Helleman, (unknown), Wichor M. Bramer, (unknown), Erik Briers, Juan Gómez Rivas, (unknown), Ondřej Májek, Lieven Annemans, (unknown), Partha Basu, (unknown), Roderick van den Bergh, Sarah Collen, Hendrik Van Poppel, Monique J. Roobol	11
3	The current role of MRI for guiding active surveillance in prostate cancer 2022 ·Nature Reviews Urology ·Guillaume Ploussard, Olivier Rouvière, Morgan Rouprêt, Roderick van den Bergh, Raphaële Renard‐Penna	24
4	Quality of early prostate cancer follow-up care from the patients’ perspective 2022 ·Supportive Care in Cancer ·(unknown), Henk G. van der Poel, Kristel M. van Asselt, Floris J. Pos, Corinne Tillier, (unknown), André N. Vis, (unknown), Roderick van den Bergh, Diederik M. Somford, Ben C. Knipscheer, Evelyne C. C. Cauberg, Marinus A. Noordzij, Neil K. Aaronson, Annelies H. Boekhout, Lonneke V. van de Poll‐Franse	1
5	Focal Therapy for Prostate Cancer: Complications and Their Treatment 2021 ·Frontiers in Surgery ·Arnas Rakauskas, Giancarlo Marra, Isabel Heidegger, Veeru Kasivisvanathan, Alexander Kretschmer, Fabio Zattoni, Felix Preißer, Derya Tilki, Igor Tsaur, Roderick van den Bergh, Claudia Kesch, Francesco Ceci, Christian D. Fankhauser, Giorgio Gandaglia, Massimo Valério	24
6	Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time? 2021 ·Frontiers in Surgery ·Fabio Zattoni, Isabel Heidegger, Veeru Kasivisvanathan, Alexander Kretschmer, Giancarlo Marra, Alessandro Magli, Felix Preißer, Derya Tilki, Igor Tsaur, Massimo Valério, Roderick van den Bergh, Claudia Kesch, Francesco Ceci, Christian D. Fankhauser, Giorgio Gandaglia	5
7	Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now? 2019 ·Cancer Treatment Reviews ·Igor Tsaur, Isabel Heidegger, Alexander Kretschmer, Hendrik Borgmann, Giorgio Gandaglia, Alberto Briganti, Pieter De Visschere, Romain Mathiéu, Massimo Valério, Roderick van den Bergh, Piet Ost, (unknown), Derya Tilki, Guillaume Ploussard, C. Surcel	23
8	Combining anticancer drugs with osteoprotective agents in prostate cancer—A contemporary update 2018 ·Urologic Oncology Seminars and Original Investigations ·Igor Tsaur, Isabel Heidegger, Alexander Kretschmer, Hendrik Borgmann, (unknown), Giorgio Gandaglia, Alberto Briganti, Roderick van den Bergh, Derya Tilki, Piet Ost, Guillaume Ploussard, C. Surcel	1
9	Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review 2018 ·European Urology ·Guillaume Ploussard, Giorgio Gandaglia, Hendrik Borgmann, Pieter De Visschere, Isabel Heidegger, Alexander Kretschmer, Romain Mathiéu, C. Surcel, Derya Tilki, Igor Tsaur, Massimo Valério, Roderick van den Bergh, Piet Ost, Alberto Briganti	85
10	Imaging modalities in synchronous oligometastatic prostate cancer 2018 ·World Journal of Urology ·(unknown), Jurgen J. Fütterer, C. Surcel, Roderick van den Bergh, Hendrik Borgmann, Alberto Briganti, Giorgio Gandaglia, Alexander Kretschmer, Piet Ost, Prasanna Sooriakumaran, Derya Tilki, Massimo Valério, Guillaume Ploussard, Pieter J. L. De Visschere, Igor Tsaur	15
11	Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies? 2018 ·World Journal of Urology ·(unknown), Guillaume Ploussard, Hendrik Borgmann, Alberto Briganti, Pieter De Visschere, Jurgen J. Fütterer, Giorgio Gandaglia, Isabel Heidegger, Alexander Kretschmer, Romain Mathiéu, Piet Ost, Prasanna Sooriakumaran, C. Surcel, Derya Tilki, Igor Tsaur, Massimo Valério, Roderick van den Bergh	36
12	Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment 2017 ·European Urology Focus ·Roderick van den Bergh, Giorgio Gandaglia, Derya Tilki, Hendrik Borgmann, Piet Ost, C. Surcel, Massimo Valério, Prasanna Sooriakumaran, Laurent Salomon, Alberto Briganti, Markus Graefen, Henk G. van der Poel, Alexandre de la Taille, Francesco Montorsi, Guillaume Ploussard	39
13	Setting an Agenda for Assessment of Health-related Quality of Life Among Men with Prostate Cancer on Active Surveillance: A Consensus Paper from a European School of Oncology Task Force 2016 ·European Urology ·Silvia Villa, Friederike Kendel, Lionne D. F. Venderbos, T. Rancati, Chris H. Bangma, Peter R. Carroll, Louis Denis, Laurence Klotz, Ida J. Korfage, J. Athene Lane, Tiziana Magnani, Ken Mastris, Antti Rannikko, Monique J. Roobol, Bruce J. Trock, Roderick van den Bergh, Hendrik Van Poppel, R. Valdagni, Lara Bellardita	7
14	Practice Patterns Compared with Evidence-based Strategies for the Management of Androgen Deprivation Therapy–Induced Side Effects in Prostate Cancer Patients: Results of a European Web-based Survey 2016 ·European Urology Focus ·Renée Bultijnck, C. Surcel, Guillaume Ploussard, Alberto Briganti, Pieter De Visschere, Jurgen J. Fütterer, Pirus Ghadjar, Gianluca Giannarini, Hendrik Isbarn, Christophe Massard, Prasanna Sooriakumaran, Massimo Valério, Roderick van den Bergh, Piet Ost	11
15	How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review 2014 ·European Urology ·Lara Bellardita, R. Valdagni, Roderick van den Bergh, (unknown), Claudia Repetto, Lionne D. F. Venderbos, J. Athene Lane, Ida J. Korfage	93
16	Anxiety and distress during active surveillance for early prostate cancer 2010 ·Roderick van den Bergh, Marie‐Louise Essink‐Bot, (unknown), Tineke Wolters, Fritz H. Schröder, Chris Bangma, Ewout W. Steyerberg	12
17	Screening: should more biopsies be taken in larger prostates? 2009 ·British Journal of Urology ·Pim van Leeuwen, Roderick van den Bergh, Tineke Wolters, Fritz H. Schröder, Monique J. Roobol	4
18	Treatment results in primary intraspinal gliomas 1993 ·Radiotherapy and Oncology ·Maarten C.C.M. Hulshof, Johan Menten, (unknown), (unknown), Roderick van den Bergh, Dionisio González	28
19	Low Grade Astrocytoma in Children Treated by Surgery and Radiation Therapy 1984 ·Acta Radiologica Oncology ·L. Dewit, E. van der Schueren, (unknown), Roderick van den Bergh, R. Dom, J. M. Brücher	27
20	Un cas de gangliocytome du cervelet. 1959 ·(unknown), Roderick van den Bergh	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact